Newark, NJ, March 25, 2008 --(PR.com
)-- Barry M. Sherman M.D., currently senior vice-president and Chief Medical Officer (CMO) of BiPar Pharmaceuticals,has begun writing for Lawrence Rothman, PhD.’s blog, http://pharmservices.blogspot.com . Pharmservices is a blog devoted to topics involving the pharmaceutical/life sciences industry covering the topics of globalization, consulting, and healthcare policy.
Dr. Sherman has had a successful career in researching and bring new drugs to market. A list of the successful NDA’s (new drug approvals) that he has led includes Protropin, Nutropin, Activase, Actimmune, Pulmozyme, CD4IgG, Relaxin, gp120, Insulin like growth factor, Nerve growth factor, Anti IgE, Oral llbllla, TNK, Thrombopoetin.
He has worked in the following drug companies: Acumen Sciences (VP and CSO), Pain Therapeutics (Executive VP and CMO), Anergen (President and CEO), and Genentech (Senior VP and CMO).
Dr. Sherman belongs to the following professional organizations: American Federation for Clinical Research, American Diabetes Association, Endocrine Society, American Association for the Advancement of Science, Society for the Study of Reproduction, American College of Physicians – Fellow, Central Society for Clinical Research, Association of Program Directors: GCRC
American Society for Clinical Investigation.
His first blog will concern the failure of Big Pharma’s industrialized approach to drug research and development.
Lawrence J. Rothman, PhD.
Contact: Larry Rothman